GLP-1 Check — India's GLP-1 Information & Self-Assessment Tool
Updated daily

GLP-1 & Semaglutide News (India)

India-first daily coverage of GLP-1 therapy — DCGI approvals, Indian generic launches (Sundae, Noveltreat, Obeda, Semabest…), price cuts, Mounjaro / tirzepatide updates, and trial readouts (STEP, SUSTAIN, SURMOUNT, SELECT).

200 articles

In India

40 articles
Indiaindiagazette.com·2 days ago

Lilly targets six US firms over black-market obesity drug

Lilly targets six US firms over black-market obesity drug indiagazette.com

IndiaTradingView·2 days ago

Zydus, Sun Pharma lead India pharma growth in July; Sun gains semaglutide share: Nomura

Zydus, Sun Pharma lead India pharma growth in July; Sun gains semaglutide share: Nomura TradingView

IndiaNAVLIN DAILY·3 days ago

India’s Sun Pharma to Seek High Court Nod Before Launching Semaglutide Tablets

India’s Sun Pharma to Seek High Court Nod Before Launching Semaglutide Tablets NAVLIN DAILY

IndiaeHealth Magazine·3 days ago

The GLP-1 revolution: Is India ready for the next era of obesity treatment?

The GLP-1 revolution: Is India ready for the next era of obesity treatment? eHealth Magazine

Research & Trials

75 articles
ResearchYahoo Creators·2 days ago

Feeling awful on your GLP-1? The drug may not be what's making you miserable

Feeling awful on your GLP-1? The drug may not be what's making you miserable Yahoo Creators

ResearchCureus·2 days ago

Comparative Efficacy and Safety of Tirzepatide Versus Semaglutide for Obesity: A Systematic Review

Comparative Efficacy and Safety of Tirzepatide Versus Semaglutide for Obesity: A Systematic Review Cureus

ResearchZME Science·3 days ago

GLP-1 Drugs Have Been Linked to More Than 200 Reported Deaths in the UK Alone

GLP-1 Drugs Have Been Linked to More Than 200 Reported Deaths in the UK Alone ZME Science

ResearchPeople.com·3 days ago

Calif. College Student, 19, Dies in U.K. Dorm Room After Taking GLP-1 Weight-Loss Drug

Calif. College Student, 19, Dies in U.K. Dorm Room After Taking GLP-1 Weight-Loss Drug People.com

Regulation

41 articles
RegulationNewswire.com·about 20 hours ago

Pallas Health GLP-1 Reviews 2026: Ready to Make Weight Management a Real Priority? Discover the Doctor-Led Online GLP-1 Option

Pallas Health GLP-1 Reviews 2026: Ready to Make Weight Management a Real Priority? Discover the Doctor-Led Online GLP-1 Option Newswire.com

RegulationMedShadow Foundation·2 days ago

FDA Recalls and Warnings: Foreign Particles Found in Compounded Semaglutide, Cancer-Causing Impurities in Bladder Drug

FDA Recalls and Warnings: Foreign Particles Found in Compounded Semaglutide, Cancer-Causing Impurities in Bladder Drug MedShadow Foundation

RegulationForbes·2 days ago

UPDATED: The Most Affordable GLP-1 Providers in 2026

UPDATED: The Most Affordable GLP-1 Providers in 2026 Forbes

RegulationThe Washington Post·3 days ago

Eli Lilly sues vendors accused of hawking versions of its experimental GLP-1

Eli Lilly sues vendors accused of hawking versions of its experimental GLP-1 The Washington Post

Global

44 articles
Globalforeignpolicyjournal.com·about 8 hours ago

Vivani Medical (NASDAQ: VANI) Completes Full Enrollment In Semaglutide Implant Trial, Strikes Novo Nordisk Deal

Vivani Medical (NASDAQ: VANI) Completes Full Enrollment In Semaglutide Implant Trial, Strikes Novo Nordisk Deal foreignpolicyjournal.com

GlobalAD HOC NEWS·1 day ago

Novo Nordisk stock steadies as Wegovy pill drives guidance tweak and court win

Novo Nordisk stock steadies as Wegovy pill drives guidance tweak and court win AD HOC NEWS

GlobalMedical Dialogues·3 days ago

Setback to Sun Pharma: Delhi HC Puts Semaglutide Launch on Hold

Setback to Sun Pharma: Delhi HC Puts Semaglutide Launch on Hold Medical Dialogues

GlobalFierce Pharma·3 days ago

Lilly takes 6 companies to court for selling retatrutide knockoffs

Lilly takes 6 companies to court for selling retatrutide knockoffs Fierce Pharma

News articles are aggregated from third-party RSS feeds. GLP-1 Check does not endorse or verify individual articles. Content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment.